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Abstract
Background: Due to problems of publication bias and selective reporting, the ICMJE requires prospective
registration of all clinical trials with an appropriate registry before the first participant is enrolled. Previous research
has shown that not all clinical trials are registered at this time (prospectively). This study investigated the extent
and timing of trial registration. The aims were to determine 1) the proportion of clinical trials that were registered
prospectively or retrospectively and 2) when retrospective registration took place in relation to submission to the
journal in which they were published.
Methods: All clinical trials published in the BMC series in 2013 were identified. All articles that met the study’s
inclusion criteria were categorised into one of three categories: 1) prospectively registered, 2) retrospectively
registered before submission to the journal in which they were published or 3) retrospectively registered after
submission to the journal in which they were published.
Results: One hundred and eight eligible studies were identified. Of these, 33 (31 %) reported studies that were
registered prospectively, 72 reported studies that were registered retrospectively (67 %) and three articles (3 %)
did not include a trial registration number. Of the 72 studies that were registered retrospectively, 66 (92 %) were
registered before the article was submitted to the journal and six (8 %) were registered after the article was
submitted to the journal.
Conclusions: Ten years after the ICMJE requirements for prospective registration of clinical trials this study found
that the majority of included clinical trials were registered retrospectively but before submission to a journal for
publication. This highlights the need for organisations other than journals, such as research institutions and grant
giving bodies, to be more involved in enforcing prospective trial registration.
Background
Many studies are never published [1], in particular,
‘negative’ studies, which are less likely to be published
than those reporting a positive outcome [1–4]. For those
clinical trials that are published, there is evidence of
selective reporting; outcomes are incompletely reported,
statistically significant outcomes are more likely to be
reported, and primary outcomes are changed [5]. Collect-
ively, these problems distort the evidence on which clin-
ical decisions are based. Clinical trial registration aims to
address these problems through the creation of a public
record of the existence of all clinical trials. Since July
2005, member journals of the International Committee of
Medical Journal Editors (ICMJE) have required registra-
tion of clinical trials to counter problems with selective
reporting and non-publication of negative results [6].
Clinical trials are defined by the World Health Organ-
isation (WHO) as “any research study that prospectively
assigns human participants or groups of humans to one
or more health-related interventions to evaluate the
effects on health outcomes.” [7]. Registration should be
with an appropriate registry and should take place before
enrolment of the first participant [8].
Despite these requirements, there is evidence that un-
registered clinical trials are published [9]. We also know
from our past experience as journal editors that journals
receive submissions of manuscripts describing clinical
* Correspondence: stephanie.harriman@biomedcentral.com
BioMed Central, 236 Gray’s Inn Road, London, WC1X 8HB, UK
© 2016 Harriman and Patel. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Harriman and Patel Trials  (2016) 17:187 
DOI 10.1186/s13063-016-1310-8
trials that have not been registered before the first par-
ticipant is enrolled. The journals of the BMC series con-
sider retrospectively registered clinical trials, as do other
journals [10]. Few studies have investigated the extent of
retrospective registration of clinical trials and at what
point clinical trials are registered.
The aim of this study was to determine:
1. the proportion of clinical trials published in the
BMC series journals during 2013 that were
registered prospectively and the proportion that
were registered retrospectively
2. for those studies that were registered retrospectively,
whether registration took place before or after
submission of the results to the journal in which
they were published.
Methods
The setting for this study was the BMC series, which is a
group of open access, peer-reviewed journals spanning
all areas of biology and medicine. It includes a series of
subject-specific journals, two highly selective journals
publishing articles of special importance or broad inter-
est and one journal publishing all sound science across
all fields of biology and medicine.
We identified all clinical trials published in all journals
of the BMC series between 1 January and 31 December
2013. To do this, a Structured Query Language (SQL)
query was written to extract all relevant articles from an
internal reporting database. The query identified all arti-
cles that were published in any of the BMC series jour-
nals in 2013 where the title or abstract contained the
word ‘trial’. All identified articles were then screened to
identify those that met the following inclusion criteria:
 publication in a journal of the BMC series in 2013
 publication as a ‘Research Article’ article
 reporting outcomes of a clinical trial, according to
the WHO definition of a clinical trial at the time of
publication of the article.
Studies were excluded if they met the following ex-
clusion criteria:
 patient enrolment began before July 2005
 articles reporting only secondary analysis of results
from previously reported clinical trial
 articles where the data reported had already been
published
 studies that did not meet the WHO definition of a
clinical trial
 pilot studies for which no health outcomes were
reported and which solely reported on feasibility
of a larger study.
All articles meeting the above inclusion criteria were
searched for the following information:
 the name of the journal in which the article was
published
 the presence of a trial registration number
 the study design (for example, randomised controlled
trial (RCT), interventional non-randomised)
 the date of submission of the manuscript to the
journal in which it was published
 the country of the affiliation given for the first
author
 whether any of the authors declared a financial
competing interest.
Where there was a trial registration number available, the
registry record was searched for the following information:
 the name of the registry in which the trial was
registered
 the date on which the trial was registered with the
trial registry
 the date of enrolment of the first participant
(as specified in the trial registry record).
Once all eligible articles had been identified and the
above data extracted, included articles were categorised
as follows:
1. Prospectively registered: defined as those where the
date of registration recorded in the trial registry
record was earlier than the date of enrolment as
recorded in the trial registry record.
2. Retrospectively registered before submission to
journal: defined as those where the date of
registration recorded in the trial registry record was
later than the date of enrolment as recorded in the
trial registration record, but before the date of
submission of the manuscript to the journal.
3. Retrospectively registered after submission to
journal: defined as those where the date of
registration recorded in the trial registry record was
later than the date of submission of the manuscript
to the journal.
For all studies that were retrospectively registered, but
registered prior to submission to the journal in which
they were published, the length of time between the start
date of the study (patient enrolment) and the date of
registration was recorded.
Some trial registries include both the date of submission/
application for trial registration and the date that the trial
registration number was granted in the trial registry record;
however, both dates are not available in all registries. For
Harriman and Patel Trials  (2016) 17:187 Page 2 of 8
those registries where both dates are available, date of
registration was used. For registries where only date
of application/submission is available (clinicaltrials.gov),
this date was taken as the date of registration. For
those registries where only date of registration is
available (ChiCTR, DRKS, NTR and UMIN-CTR), this
date was used.
Terminology for the date of enrolment of the first par-
ticipant differs between trial registries; for example, in clini-
caltrials.gov it is given as ‘study start date’ and in ISRCTN
as ‘anticipated start date’. Where only one date was given
(clinicaltrials.gov and ISRCTN), this was considered to be
the date of enrolment of the first participant. Where only
the month and year were available (clinicaltrials.gov), the
date of enrolment was taken to be the last day of the
month. Where a trial registry report gave both an antici-
pated and actual date of enrolment (ANZCTR), the actual
date was considered to be the date of enrolment.
The results are presented as absolute numbers with
percentages and as medians with interquartile ranges
where appropriate.
Results
One hundred and eight articles met the study’s inclusion
criteria and were included in this study (see Fig. 1).
Characteristics of the included studies are shown in
Table 1. The articles were published across 21 different
journals within the BMC series, all of which were medical
journals. The clinical trials they reported were registered in
eight different trial registries. The most common study de-
sign reported was RCT (83). Thirteen articles reported
other interventional studies that did not involve randomisa-
tion and 12 reported pilot RCTs (where a health outcome
was assessed in addition to feasibility of the intervention for
a larger study). Based on country of affiliation of the first
author, included trials were from 30 countries across six
Fig. 1 Number (and % of total included studies) of identified clinical trials registered at different stages
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continents. The largest group of studies were from Europe
(47 %). Financial competing interests were declared in 16
(15 %) of the included articles. See Table 2.
Of the 108 articles, 33 (31 %) reported studies that
were registered prospectively, 72 reported studies that
were registered retrospectively (67 %) and three articles
(3 %) did not include a trial registration number. Of the
72 studies that were registered retrospectively, 66 (92 %)
were registered before the article was submitted to the
journal and six (8 %) were registered after the article was
submitted to the journal.
Table 1 Characteristics of included studies: number and
percentage of included articles/studies by journal in which the
article was published, trial registry in which the trial was registered,
study design, continent of the first authors’ affiliation, and presence
or absence of a declared financial competing interest
Study characteristics All studies
(% of total 108)
Journal in which published
- BMC Anaesthesiology 1 (1)
- BMC Cancer 2 (2)
- BMC Complementary and Alternative Medicine 10 (9)
- BMC Cardiovascular Disorders 2 (2)
- BMC Dermatology 1 (1)
- BMC Emergency Medicine 3 (3)
- BMC Endocrine Disorders 1 (1)
- BMC Family Practice 11 (10)
- BMC Gastroenterology 8 (7)
- BMC Geriatrics 9 (8)
- BMC Health Services Research 5 (5)
- BMC Infectious Diseases 6 (6)
- BMC International Health and Human Rights 1 (1)
- BMC Medicine 7 (6)
- BMC Musculoskeletal Disorders 2 (2)
- BMC Nephrology 9 (8)
- BMC Pediatrics 8 (7)
- BMC Pregnancy and Childbirth 4 (4)
- BMC Psychiatry 7 (6)
- BMC Public Health 9 (8)
- BMC Pulmonary Medicine 2 (2)
Trial registry
- ANZCTR 11 (10)
- CHiCTR 3 (3)
- Clinicaltrials.gov 63 (58)
- DRKS 3 (3)
- IRCT 2 (2)
- ISRCTN 15 (14)
- NTR 4 (4)
- UMIN-CTR 4 (4)
Study design
- RCT 83 (77)
- Pilot RCT 12 (11)
- Interventional, non-randomised 13 (12)
Continent of affiliation (first author)
- Africa 2 (2)
- Asia 24 (22)
- Australia 11 (10)
- Europe 51 (47)
Table 1 Characteristics of included studies: number and
percentage of included articles/studies by journal in which the
article was published, trial registry in which the trial was registered,
study design, continent of the first authors’ affiliation, and presence
or absence of a declared financial competing interest (Continued)
- North America 14 (13)
- South America 6 (6)
Financial competing interests (CI) of any author
- Financial CI declared 16 (15)
- No financial CI declared 92 (85)
Table 2 Distribution of 108 included articles by study
characteristics (study design, continent of first author’s affiliation,
and presence or absence of a declared financial competing
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For studies that were registered retrospectively, but
before submission to the journal in which they were
published, registration took place between five and 1677
days after enrolment of the first participant. The median
number of days between enrolment of the first partici-
pant and registration was 356 (IQR 109.3–868). Eleven
studies were registered within one month (30 days) of
enrolment of the first participant. We also looked at
whether there were differences in time of registration
within different fields. Median and IQR were calculated
for the four journals that published the highest number
of clinical trials that were registered retrospectively be-
fore submission to the journal (BMC Complementary
and Alternative Medicine, BMC Family Practice, BMC
Pediatrics and BMC Public Health) (see Table 3).
There were three articles that were categorised as not
including a TRN. Two of these did not include a TRN in
the published article and no record of the clinical trial
could be found by searching the International Clinical
Trials Registry Platform search portal. The other article
did contain a TRN for the registry EudraCTR; however,
we were unable to locate the record for this clinical trial
using the TRN given. The corresponding author for each
of these articles was contacted by email to ask whether
the study had been registered. One confirmed that the
study was not registered, one did not reply, and the un-
obtainable EudraCTR number was confirmed but it was
still not possible to locate the record. This was therefore
categorised as not registered.
Discussion
The majority of clinical trials reported in the articles in-
cluded in this study were registered retrospectively, but
before submission to the journal in which they were
published. Only a very small number (n = 3) did not re-
port a TRN. This compares favourably with a previous
study of a sample of RCTs which found that the TRN
was reported in the published article for 55 % of RCTs
indexed in MEDLINE and 60 % of RCTs registered in
NTR [11]. It is also lower than a study of RCTs pub-
lished in the ten highest ranked surgical journals by im-
pact factor which found that 35 % of included clinical
trials were not registered [12].
There are several possible reasons why a clinical trial
may not be registered prospectively. Some researchers
may not be aware of trial registration and the need to
register their clinical trial. Researchers may be aware of
trial registration, but not realise that their study meets
the definition of a clinical trial, particularly those that
are not RCTs. It is also possible that researchers may de-
liberately choose not to register to avoid publishing
‘negative’ results or to enable them to change primary
outcomes or selectively report outcomes. Low support
among trialists for trial registration has previously
been observed, with a 2007 survey finding that only
21 % of respondents had registered all on-going trials
since 2005 and only 47 % stated they would register
future clinical trials [13].
Clinical trials that were registered retrospectively were
registered at different times between first participant en-
rolment and submission to the journal in which they
were published. This would appear to reflect a lack of
importance applied to trial registration. Although it is
done eventually, it appears to be seen as merely an ad-
ministrative exercise that can be done at any time. Regis-
tration around the time of participant enrolment may be
due to different members of the research team conduct-
ing different elements of the process of setting up the
clinical trial, or due to the large number of different
tasks trialists must complete at this stage. Registration
nearer the time of submission may be due to an earlier
submission to another journal from which the manu-
script was rejected, or the researchers reading the jour-
nal’s ‘Instructions for Authors’. Retrospective registration
after submission is likely to be in response to the Editor
requesting that the authors register the study.
ICMJE policies require registration of clinical trials
before enrolment of the first participant, and editorial
policies of member journals reflect this [6]. Despite this,
journals receive submissions of articles reporting clinical
trials that have not been registered prospectively. Editors
must decide whether to consider such submissions.
There are ethical arguments for and against consideration
of clinical trials that were not registered prospectively.
Retrospective registration negates many of the benefits of
trial registration such as preventing non-publication of so
called ‘negative’ studies, selective reporting, or changing of
primary outcomes. Considering retrospectively registered
clinical trials may also undermine attempts to increase pro-
spective registration by removing some of the incentive for
researchers to register prospectively.
Conversely, clinical trials involve human participants
who have taken part in medical research, giving their
time and exposing themselves to risk on the understand-
ing that the research will be published and potentially
benefit future patients. By refusing to publish retrospect-
ively registered clinical trials, journals would be causing
Table 3 Median number of days between first participant
enrolment and registration for retrospectively registered studies in







491 448 to 1172
BMC Family Practice 418.5 139.5 to 676.25
BMC Pediatrics 745 243 to 1273
BMC Public Health 321.5 148.5 to 1239.25
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non-publication of research involving humans and also
contributing to publication bias. For this reason, there
have also been calls for the retrospective registration of
all trials that were not registered in the past [14–16].
If journals do consider clinical trials that were not
registered prospectively, they should define the condi-
tions under which such trials would be considered.
For example, one option would be to only publish
retrospectively registered clinical trials if researchers
were genuinely unaware of the requirement for registra-
tion. While editors can ask authors for an explanation as
to why their trial was not prospectively registered, they
would not be able to ascertain with certainty that the re-
searcher truly did not know that their trial required regis-
tration, potentially making this option unfeasible. In
addition, not requiring retrospective registration of all un-
registered studies means that if the manuscript is rejected,
there is no publicly available record of that clinical trials’
existence, which may lead to non-publication elsewhere.
Another option could be for journals to include date
of registration of the trial, a ‘retrospectively registered’
flag, or an explanation from the authors for why the trial
was not registered prospectively. This would make the
registration status of a publication more transparent,
allowing readers to judge the research accordingly. The
BMC series currently asks authors to indicate the date
the trial was registered when presenting the trial regis-
tration number in the abstract.
There is little research into timing of trial registration,
and this study provides important information highlight-
ing the extent of retrospective registration of published
clinical trials. Our results differ from those of Huser and
Cimino, who found that 60 % of clinical trials were reg-
istered before participant enrolment. There are a num-
ber of possible reasons for this. There are differences in
the journals included; their study included only the five
ICMJE founding journals with 2011 Impact Factors of
≥10.0 [9]. These journals differ in a number of ways
from the BMC series, including Impact Factor and
threshold. Our methodology also differs to that used by
Huser and Cimino. We applied strict criteria for classify-
ing a study as retrospectively registered. Those regis-
tered the day after enrolment of the first participant
were counted as retrospective. This is based on similar
criteria used by trial registries that add a ‘retrospectively
registered’ flag to trial registry records [personal com-
munication with ISRCTN]. Husser and Cimino applied
more generous criteria, allowing a 60-day grace period,
to account for the 21-day grace period allowed by US
law [17] and data quality assurance processes [9].
Compared to our results, Hardt et al. also found a lower
percentage of retrospectively registered studies when look-
ing at registration of RCTs published in surgical journals
[18]. Again, these included journals may have differed to
the BMC series in that the study by Hardt et al. looked
only at the ten highest ranked (by Impact Factor) surgical
journals. Our study also used the WHO definition of a
clinical trial, which is broader than just RCTs. In another
study involving surgical journals, this time looking at
RCTs published in the ten surgical journals with the high-
est Impact Factors, Killeen et al. found that 21 % were reg-
istered after completion of the study [12].
Our study also shows a greater percentage of retro-
spectively registered clinical trials in contrast to other
studies of retrospective registration of clinical trials. For
example, Viergever and Ghersi [19, 20] found that
around half were retrospectively registered. This differ-
ence may be due to differences in study design, as these
studies looked at a sample of trial registry records [19, 20],
while our study looked at published articles. The clinical
trials registered in the trial registry may differ from those
clinical trials published in the BMC series.
Limitations
Our study has a number of limitations. It is limited by
the variation in presentation and quality of information
as well as the amount of required information between
different trial registries. For example, there is a lack of
consistency between registries in the date given for regis-
tration. While some registries publish both date of submis-
sion of the application and date registration was granted,
some registries only include date of submission to the
registry or date of granting registration. There is also a lack
of consistency between terminology regarding study start
dates, and accuracy of this date; for example, registries may
report ‘study start date’, ‘anticipated start date’, or ‘actual
start date’. The quality clinical trial registry records have
previously been identified as inconsistent [19, 20].
Although it has never actively encouraged it, the BMC
series has always been willing to consider retrospectively
registered studies. This may mean its journals receive a
greater number of submissions and consequently publica-
tions reporting retrospectively registered studies compared
to other journals that either do not publish retrospectively
registered studies or have only recently changed to con-
sider them. This may be one reason for the high number
of retrospectively registered studies identified in our study
compared with Huser and Cimino’s [9].
Another limitation is that we do not know whether
manuscripts had been previously rejected from other jour-
nals before submission to the BMC series journal in which
they were published. During an earlier submission to an-
other journal, authors may have been asked to retrospect-
ively register their trial. We were not able to determine
how far this occurred in our sample of articles.
It is possible that the BMC series’ reputation for consider-
ing retrospectively registered clinical trials discouraged re-
searchers from registering prospectively. Although journals
Harriman and Patel Trials  (2016) 17:187 Page 6 of 8
do play a role in promoting prospective trial registration via
policies that incentivise prospective registration, they are
not well placed in the process of scientific research to en-
sure that prospective registration takes place. Except in the
case of study protocols, editors do not encounter clinical
trials until long after they are completed, at which point it
is too late. Furthermore, it is unlikely that any single journal
editor or publisher can change the behaviour of researchers
who do not view clinical trial registration as an important
part of the research and publication process. As long
as authors have somewhere to publish their findings,
journal editors and publishers remain relatively weak.
Other stakeholders, earlier in the process, need to be
involved in setting out internationally agreed require-
ments, similar to those for the ethical conduct of human
research, which journal editors and publishers can en-
force. In this way, ethics committees, institutions, and
funders are arguably better placed to enforce prospective
registration. For example, in the UK, the Health Research
Authority has made trial registration a condition of
receiving ethics approval [21].
Another limitation is the definition of a clinical trial.
We applied the WHO definition of a clinical trial [7].
Initial ICMJE requirements for registration were “any re-
search project that prospectively assigns human subjects
to intervention or comparison groups to study the cause-
and-effect relationship between a medical intervention
and a health outcome”. This excludes those only examin-
ing pharmacokinetics or toxicity [6]. For all trials begin-
ning participant enrolment from 1 July 2008 onwards, the
ICMJE has used the WHO definition of a clinical trial
[22]. We also identified manuscripts for inclusions using
the word ‘trial’. It is possible that this could have led to
missed studies.
Our sample size was too small to determine whether
certain factors (such as competing interests or geograph-
ical location of authors) were associated with prospective
versus retrospective registration.
Conclusions
Despite the requirement for prospective registration of
clinical trials in many journals for the past ten years, this
study is the first to show that a large number of clinical
trials were not prospectively registered.
The lack of prospective registration identified in this
study demonstrates that more needs to be done to im-
prove adherence to prospective registration. It also high-
lights the importance of allowing retrospective trial
registration of studies that have not been prospectively
registered in order to prevent the non-publication of po-
tentially valuable research for which human participants
have given up their time and exposed themselves to risk.
The results also suggest that there is a need for clear
linkage of published articles reporting clinical trials to
their trial registry records. This, along with the transpar-
ent inclusion of the date of registration in the published
article and clear indication in the trial registry record
when a trial has been registered retrospectively, will in-
crease transparency and ensure that readers are aware of
whether a clinical trial has been prospectively or retro-
spectively registered.
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